Pharming Group
PHAR
4 hedge funds and large institutions have $434K invested in Pharming Group in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
16% less capital invested
Capital invested by funds: $514K → $434K (-$80.4K)
20% less funds holding
Funds holding: 5 → 4 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.69K |
| 2 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
+$950 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4.86K |
| 2 |
FFA
Farther Finance Advisors
San Francisco,
California
|
-$111 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$101 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SBCM
1
Silverberg Bernstein Capital Management
Armonk,
New York
| $402K | – | – | – |
|
|
2
Morgan Stanley
New York
| $24.3K | +$2.69K | +300 | +12% |
|
|
NSG
3
Nalls Sherbakoff Group
Knoxville,
Tennessee
| $7.28K | +$7.8K | +870 | New |
|
|
CCM
4
Coldstream Capital Management
Bellevue,
Washington
| $887 | +$950 | +106 | New |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| – | -$4.86K | -483 | Closed |
|
|
FFA
6
Farther Finance Advisors
San Francisco,
California
| – | -$111 | -11 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$101 | -10 | Closed |
|
PHAR Hedge Fund Activity: Q1 2025 in Review
4 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q1 2025, worth a combined $434K — down 16% from $514K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PHAR and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $2.69K. The largest seller was Osaic Holdings, exiting entirely with an estimated $4.86K sold.
- 4 institutional investors held Pharming Group (PHAR) as of Q1 2025, down from 5 in Q4 2024.
- Funds reported $434K of Pharming Group stock for Q1 2025, down 16% quarter-over-quarter.
- 2 funds opened new Pharming Group positions in Q1 2025 and 3 closed out, a net change of -1 holder.
- The largest Pharming Group buyer in Q1 2025 was Morgan Stanley, an estimated $2.69K added.
- The largest Pharming Group seller in Q1 2025 was Osaic Holdings, an estimated $4.86K sold.
Based on aggregated 13F filings for Q1 2025.